Clinical Trials Directory

Trials / Completed

CompletedNCT02744404

Point of Care Early Infant Diagnosis Patient Impact Study

Evaluation of the Clinical Impact of Point-of-Care HIV Early Infant Diagnostic Technologies

Status
Completed
Phase
Study type
Observational
Enrollment
1,752 (actual)
Sponsor
Clinton Health Access Initiative Inc. · Academic / Other
Sex
All
Age
12 Months
Healthy volunteers
Accepted

Summary

In Malawi, early infant HIV diagnosis (EID, i.e. HIV screening of infants under 18 months of age) is conducted using molecular diagnostics at central laboratories. However, test volumes are growing and many parts of the country do not have close or easy access to laboratories. Test samples are transported over large distances and this can introduce testing delays, especially for patients in rural and remote areas of the country. There are growing numbers of high quality Point-Of-Care (POC) diagnostic technologies available and there is increasing interest in using these technologies to alleviate critical testing needs. This protocol describes an observational study looking at the patient impact of implementing POC EID technologies within the routine standard of care at seven facilities.

Conditions

Interventions

TypeNameDescription
DEVICEPOC EID

Timeline

Start date
2015-09-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2016-04-20
Last updated
2018-07-27

Locations

7 sites across 1 country: Malawi

Source: ClinicalTrials.gov record NCT02744404. Inclusion in this directory is not an endorsement.

Point of Care Early Infant Diagnosis Patient Impact Study (NCT02744404) · Clinical Trials Directory